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Background: Transgenic mosquito strains are being developed to contribute to the control of dengue and malaria
transmission. One approach uses genetic manipulation to confer conditional, female-specific dominant lethality
phenotypes. Engineering of a female-specific flightless phenotype provides a sexing mechanism essential for
male-only mosquito, release approaches that result in population suppression of target vector species.
Methods: An approach that uses a female-specific gene promoter and antibiotic-repressible lethal factor to
produce a sex-specific flightless phenotype was adapted to the human malaria vector, Anopheles stephensi.
Transposon- and site-specific recombination-mediated technologies were used to generate a number of transgenic
An. stephensi lines that when combined through mating produced the phenotype of flight-inhibited females and
flight-capable males.
Results: The data shown here demonstrate the successful engineering of a female-specific flightless phenotype in a
malaria vector. The flightless phenotype was repressible by the addition of tetracycline to the larval diet. This
conditional phenotype allows the rearing of the strains under routine laboratory conditions. The minimal level of
tetracycline that rescues the flightless phenotype is higher than that found as an environmental contaminant in
circumstances where there is intensive use of antibiotics.
Conclusions: These studies support the further development of flightless female technology for applications in
malaria control programmes that target the vectors.
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Methods are being developed to control transmission of
vector-borne diseases based on transgenic mosquitoes car-
rying a conditional dominant lethal gene (release of insects
carrying a dominant lethal [RIDL]) [1-5]. The principal
dengue virus vector, Aedes aegypti, was engineered in one
RIDL-based approach to carry a transgene conferring a re-
pressible female-specific flightless phenotype (fsRIDL) [2].
The sex-specificity of the phenotype results from the* Correspondence: aajames@uci.edu
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reproduction in any medium, provided the orregulatory DNA of the Ae. aegypti gene, Ae. aegypti Actin-
4 [2,6], that encodes a female-specific flight muscle
protein. These strains are showing promising results in
meeting the goal of new tools for dengue vector popula-
tion suppression although further refinements are neces-
sary [7,8]. The technology also was shown to work in a
related species, Aedes albopictus [4]. The technological ad-
vances achieved with Aedes species are potentially applic-
able to anophelines that transmit malaria parasites.
Features that contribute to the suitability of an fsRIDL-
based, population-suppression tool for controlling malaria
transmission include that the vector species is the major
one responsible for malaria transmission in a defined geo-
graphical region and that controlling transmission will
have a meaningful impact on local disease incidence andal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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supplemented if the proposed species were endemic to a
country that had in place robust malaria control
programmes with which to interact and the target areas
were of a reasonable scale. Geographic and ecological
islands represented by confined urban and semi-urban
areas would be ideal for evaluating the impact of the
population suppression strain on the target species. Mal-
aria transmission by Anopheles stephensi in urban and
peri-urban settings in the Indian subcontinent appears to
meet these criteria [9-11]. Malaria is endemic to the
Indian subcontinent where 70–100 million cases per year
are reported [12]. Successful application of molecular-
genetic approaches to controlling malaria transmission by
An. stephensi is expected to have a major effect on the dis-
ease burden of one of the most populous places in the
world. Anopheles stephensi is recognized as having two
forms that may be isolated reproductively and a third
intermediate form [13,14]. The type-form is found princi-
pally in urban areas where it is responsible for the major-
ity, if not all, of malaria transmission that occurs in cities.
It breeds in peridomestic water containers and is highly
anthropophilic. Distribution and feeding habits create
functional “genetic islands” defined by breeding sites and
hosts. A rural form, ‘mysorensis’, is found in the arid coun-
tryside and is not a major vector of malaria. The role of
the intermediate form in transmission is unclear. There-
fore, the urban mosquitoes are good targets for an
fsRIDL-based, population-suppression tool.
The data presented here demonstrate that it is possible
to engineer An. stephensi with a repressible female-specific
flightless phenotype based on the use of the female-specific
flight muscle promoter. These results support the prospect




A colony of An. stephensi (gift of M Jacobs-Lorena, Johns
Hopkins University) bred at the UCI insectary for longer
than five years was used in the experiments. Insects were
maintained at 27°C with 77% humidity and 12 hr day/
night, 30 min dusk/dawn lighting cycle. Larvae were fed a
diet of powdered fish food (Tetramin) mixed with yeast.
Adults were provided ad libitum with a 0.3M sucrose so-
lution in water and anesthetized mice were used for blood
feeding when required. The blood-feeding protocol was
approved by the Institutional Animal Care and Use Com-
mittee of the University of California, Irvine (NIH Animal
Welfare Assurance number: A3416.01; approved February
20, 2008), Protocol Number: 1998–1411 (approved May
17, 2012). Transgenic and control non-transgenic (wild-
type) mosquitoes were reared using the same standardized
insectary procedures, unless otherwise indicated.Identification of the Aedes aegypti Actin-4 gene
orthologue in Anopheles stephensi
Primary nucleotide sequences of the Ae. aegypti Actin-4
(AeAct-4, AY531222) gene were used to search Vectorbase
[15] for an orthologue in the genome and transcriptome
of An. stephensi. The lowest e-value and highest score
were assigned to ASTM009772. The reciprocal best
BLAST hit strategy supports the 1:1 orthology of AeAct-4
and ASTM009772. ASTM009772 is designated hereafter
as AsAct-4.
Total RNA samples extracted with TRIZOL from larvae
(mixed sexes), and separately from males and females,
pupae and adults were treated with RNAse-free DNAse
and served as templates for Reverse Transcriptase-PCRs,
using a gene-specific pair of primers complementary to
sequences located in the first and second exons of
ASTM009772 (AsActin4 exon1for 5′-CACATAGTTGT
TAGCTGGGAGAGC-3′, and AsActin4 5RACE 5′-CAG
ATCCATACGCAGGATAGCATG-3′).
The transcription start-site and intron location of AsAct-
4 was identified by 5′RACE and RT-PCR techniques. 5′
RACE was performed using the Ambion FirstChoice
RLM-RACE kit using the gene-specific primer AsActin4-
5RACE. Comparison of cDNA (5′RACE and RT-PCR
products) and An. stephensi genomic DNA, scaffold 01062
[15] sequences revealed one intron in the 5′UTR.
Mosquito transgenesis, embryo microinjection and
Southern-blot hybridization analyses
Microinjection of the pBac-IE1-DsRed2-AeAct4-tTA driver
construct (OX3545) [2] with the piggyBac helper plasmid
[16] in An. stephensi embryos was performed as described
previously [17]. OX3545 contains the AeAct-4 promoter
and first intron cloned at the 5′ end of tTAV linked to a
SV40 3′ UTR, as described previously [2]. This gene cas-
sette was inserted into a piggyBac vector containing the
Hr5-IE1 promoter driving a gene encoding the fluorescent
protein DsRed, to facilitate identification of transgenic mos-
quitoes. The helper plasmid phsp-pBac [16] has DNA se-
quences that drive constitutive expression of functional
piggyBac transposase that catalyzes random insertions of
the driver construct into the mosquito genome.
Each G0 male was mated with fifteen virgin females and
groups of ten G0 females were mated with five males. The
G1 progeny and the subsequent generations were screened
at the larval stage with fluorescence microscopy for the
expression of the DsRed marker gene. Transgenic lines
were maintained as hemizygous by out-crossing transgenic
individuals at every generation with wild-type mosquitoes.
Southern blotting and hybridization techniques were used
to detect transgene integration and copy number. Gen-
omic DNA extracted from groups of six transgenic or
wild-type control females was fractionated by agarose gel
electrophoresis and transferred to Zeta-probe GT
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CA) as described previously [18] and using standard pro-
tocols [19]. The probe used to identify transgene integra-
tions consisted of the DsRed2 ORF and was amplified
from the OX3545 plasmid using the primers 5′-GCAGC
TGATCACGTACGCTC-3′ and 5′-GTGCGCTCGTACT
GCTCCAC-3′ and labelled with 32P using the Megaprime
DNA labelling system (Amersham).
The AsAct-4 promoter and 5′UTR were used to
make the driver construct, pBac-IE1-DsRed2-AsAct4-tTA
(AsOX3545). A DNA fragment including 1014 base pairs
(bp) of the 5′-end gene sequence, the first exon (96 bp),
and the complete intron (271 bp) was amplified with the
primers AsPforEcoRV (5′-GATATCCGAGTAGTGGGT
GCTACTGTAGCG-3′) and AsPrevSpeI (5′-ACTAGTG
CCGAGTGTTATGGATTGTCCTGCAGG-3′). The amp-
lified DNA was digested with EcoRV and SpeI restriction
endonucleases and the resulting fragment cloned into
OX3545 digested previously with NruI and SpeI. Micro-
injection of AsOX3545 in An. stephensi embryos and ana-
lyses of the resulting transgenic lines were performed as
described above.
The effector construct attB-3×P3-DsRed2-tetO-Nipp1Dm
(OX3547) [2] was injected into embryos of the docking-site
strain, attP43 [20] together with in vitro-transcribed φC31
integrase mRNA [21]. The φC31 integrase catalyses recom-
bination between the attB site in the plasmid and the attP
site in the genome of the docking site strain, promoting site-
specific integration of transgenes in the target genome.
OX3547 contains the regulatory sequence of a tetracycline
responsive element (tRE), comprising multiple copies of the
tetO sequence, to which tTA binds, and a basal promoter
driving expression of the effector molecule, Nuclear Inhibitor
of PP1 (Nipp1Dm). Nipp1Dm overexpression induces phe-
notypes that include lethality, abnormal mitotic figures and
defects in muscle development [2,22,23]. tTA cannot bind to
tetO in the presence of tetracycline and expression of
Nipp1Dm remains uninduced.
The survivors of OX3547 injections were grouped into
female and male pools and out-crossed with wild-type,
non-transgenic mosquitoes of the opposite sex. The off-
spring were screened as larvae with fluorescence micros-
copy for the expression of the fluorescent DsRed marker.
Genomic DNA extracted from groups of six females was
fractionated by agarose gel electrophoresis and transferred
to Zeta-probe GT Genomic Tested Blotting Membranes
(Bio-Rad, Hercules, CA). Southern blots to evidence trans-
gene integration were performed as described above and
used the same 32P-labelled DsRed2 ORF probe.
Generation of conditional flightless mosquitoes and
tetracycline rescue of the phenotype
Conditional flightless female mosquitoes were generated
by crossing males or females hemizygous for the driverconstructs with those of the opposite sex hemizygous for
the effector construct. Progeny were screened as larvae
with fluorescence microscopy for the expression of the
marker genes. The DsRed2-encoding marker gene is the
same in the driver and effector lines, however the driver
lines express red fluorescent protein in a scattered pat-
tern throughout the body under the control of the IE1
promoter while DsRed2 expression in the effector lines
is driven by the eye-specific promoter, 3×P3. Progeny of
crosses of the driver and effector lines presenting both
the IE1 and the 3×P3 driven fluorescence patterns were
selected for further analyses. The double-hemizygous in-
dividuals were raised to adults and the survival of males
and females as well as frequency of adult flightless
phenotype scored. Adult females were considered flight-
less when they could not elevate and remain aloft after
the mosquito cages were agitated. Flightless females tend
to walk, may be able to hop but do not fly for even short
distances. Alternatively, double-hemizygous progeny
were raised in the presence of tetracycline added to the
water during larval development. Adults were offered a
0.3M sucrose solution supplemented with tetracycline
(the same concentration used for rearing larvae) and
allowed to feed ad libitum. The survival of tetracycline-
treated males and females, and frequencies of marker
gene and adult flightless phenotypes were scored.
Results
Transgene constructions
Two existing transgene constructs, previously used for
genetic transformation of Ae. aegypti, and a third, novel
construct were used in the experiments (Figure 1). Re-
placement of the AeAct-4 gene 5-end sequence (putative
promoter and first intron) with the orthologous DNA
from AsAct-4 originated the novel driver construct
(AsOX3545). Putative orthology of the Ae. aegypti AeAct-
4 and An. stephensi ASTM009772 genes was assigned by
sequencing (Additional file 1: Figure S1) and reciprocal
Blast analysis. Blastp using the predicted AeAct-4 protein
sequence as query identified ASTM009772-PA as the best
hit within the An. stephensi proteome (E-value = 0.0,
Score = 2010, Identity = 99.2%). The reciprocal blast, using
ASTM009772-PA as query identified AeAct-4 as the
best hit within the Ae. aegypti proteome (E-value = 0.0,
Score = 2010, Identity = 99.2%). The orthology assignment
is supported further by gene expression analyses showing
that in An. stephensi ASTM009772-RA transcripts are
present in fourth instar larvae (mixed sexes) and female
pupae, and absent in male pupae and adults, a pattern
similar to that of AeAct-4 [2,6].
Generation of transgenic driver lines
A total of 1,423 An. stephensi embryos injected with the
OX3545 driver construct and piggyBac helper plasmid
Figure 1 Schematic representations of the transformation constructs OX3545, AsOX3545 and OX3547, and the mechanism of action of
the double transgene-based female-specific RIDL. OX3545 and OX3547 were previously described in detail [2]. AsOX3545 is a similar to OX3545,
with the Anopheles stephensi Actin-4 regulatory sequences replacing the Aedes aegypti Actin-4 sequence. Actin 4 promoters (Act4P) drive the expression
of the tetracycline-repressible transactivator protein (tTa) in the flight muscles of adult female mosquitoes. tTA binds tetO in the absence of tetracycline,
driving expression of the effector molecule, Nuclear Inhibitor of PP1 (Nipp1Dm) [22,23], leading to disruption of normal cell functions. Tetracycline
prevents tTa binding to tetO abolishing expression of Nipp1Dm. The positions of the SpeI recognition and cleavage sites in OX3545, AsOX3545 and
OX3547 are indicated by vertically oriented arrows. Horizontally oriented arrows indicate the direction of transcription for each component of the
constructs. Abbreviations: pBac R and L, piggyBac right and left inverted repeats, respectively; attB, φC31 recombination site; DsRed2, red fluorescent
protein open reading frame; IE1, baculovirus immediate-early gene promoter driving DsRed2 expressed throughout the body; 3×P3, artificial promoter
consisting of a multimer of the binding site (P3), driving high levels of expression in the eye.
Table 1 Sex ratio and survival of driver transgenic lines
















DAa-1 ♂ 1 ♂ 325 199 0 17
DAa-2 ♂ 4 ♂ 680 138 21 22
DAa-3 ♂ 1 ♂ 200 86 3 29
DAa-4 ♂ 17 ♂ 1140 659 31 134
DAa-5 ♂ 4 ♂ 90 45 3 11
DAa-6 ♀ 1 ♂ 70 44 22 9
DAa-7 ♀ 1 ♂ 100 45 9 15
DAa-8 ♀ 1 ♂ 90 30 10 17
DAa-9 ♂ 1 ♂, 2 ♀ 0 0 0 0
DAa-10 ♂ 1 ♂ 0 0 0 0
DAa-11 ♂ 2 ♂ 0 0 0 0
DAa-12 ♂ 1 ♂ 0 0 0 0
DAa-13 ♂ 2 ♂ 0 0 0 0
DAa-14 ♂ 1 ♂ 0 0 0 0
DAa-15 ♂ 1 ♀ 0 0 0 0
*A flightless phenotype was not observed in males or females. An expanded
Table showing results of five generations is provided as Additional file 2: Table S1.
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ing into adults. These G0 adults were back-crossed with
the wild-type, non-transgenic recipient strain and 31
produced DsRed2 fluorescent G1 larvae for an estimated
transformation efficiency of ~7%. All DsRed2 fluorescent
progeny from 16 of the 31 outcrosses died during their
pre-imago stages and hence adults were recovered from
only 15 matings. These transgenic lines were designated
DAa-xx, indicating that they are driver lines carrying a
transgene with the Ae. aegypti Actin-4 regulatory se-
quence. Eight of the G1 driver lines (DAa-1, 2, 3, 4, 5, 6,
7 and 8) produced viable transgenic offspring when
crossed with wild-type mosquitoes (Table 1). All driver
lines derived from injections with the OX3545 construct
exhibited some degree of lethality during metamorphosis
of the G2 mosquitoes, with line DAa-1 showing only 8%
survival. Survival in line DAa-1 increased to 24% by the
fifth generation (G5) post injection (Additional file 2:
Table S1). All driver lines produced a higher percentage
of adult males in generations G2 through G5 than was
observed in control lines. Southern blot analyses of gen-
omic DNA isolated from G5 adult mosquitoes indicate
distinct transgene integration events in each of the char-
acterized lines (Figure 2). All lines had hybridization sig-
nal consistent with a single insertion of the driver
construct in the An. stephensi genome.
The driver construct containing the An. stephensi
Actin-4 regulatory DNA, AsOX3545, was injected in
995 embryos, resulting in 408 (41% survival) G0 adults.
Twenty-one transgenic lines (~5% transformation effi-
ciency), designated DAs-xx, were generated after out-
crossing G0 adults with the wild-type strain (Table 2).For one line, DAs-16, all transgenic females were flight-
less. This phenotype was not repressed by rearing on tetra-
cycline. Southern blot analyses revealed a variable number
of transgene insertions, ranging from one (lines DAs-28
and DAs-30) to at least four in line DAs-20 (Figure 2).
1 2 3 4 5 6 24 20 21 28 25 26 18 30 43* 1 2 3 4
-E-saD-aAD
Figure 2 Southern blot detection of transgenes integrated into the genomes of Anopheles stephensi driver and effector transgenic
lines. Genomic DNA extracted from a pool of mosquitoes from each line was digested with SpeI, fractionated by agarose gel electrophoresis,
transferred to a Zeta-probe GT membrane and hybridized to a 32P-labelled DsRed2 open-reading frame probe. DAa, DAs and E and the numbers
on top of the figures indicate the individual transgenic lines originated from injection of the OX3545 and AsOX3534 driver and OX3547 effector
constructs, respectively.





Transgenic adults Wild-type larvae Transgenic larvae Transgenic adults
Females Males
flightless/flying flying
DAs-16 1 ♂ 120 119 33/0* 33
DAs-17 17 ♂ 300 101 4/21 36
DAs-18 33 ♂ 300 131 2/19 51
DAs-19 1 ♂ 210 129 0/53 48
DAs-20 2 ♂ 320 321 0/21 65
DAs-21 4 ♂ 510 202 0/37 95
DAs-22 1 ♂ 260 176 0/21 48
DAs-23 1 ♂ 170 147 0/19 52
DAs-24 1 ♂ 410 344 0/19 32
DAs-25 14 ♂ 350 168 0/19 35
DAs-26 27 ♂ 400 107 0/29 39
DAs-27 4 ♂ 70 62 0/4 20
DAs-28 1 ♂ 130 163 0/3 35
DAs-29 10 ♂ 410 178 0/8 17
DAs-30 1 ♂ 120 144 0/9 6
DAs-31 1 ♀ 300 46 0/3 3
DAs-32 1 ♀ 500 32 0/4 14
DAs-33 1 ♀ 450 37 0/4 3
DAs-34 2 ♂ 90 54 0/0 3
DAs-35 1 ♀ 400 47 0/0 6
DAs-36 3 ♂ 40 13 0/0 1
*The flightless female phenotype of line DAs-16 is not rescued by tetracycline.
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Transgenic adults Outcross Transgenic larvae Transgenic adults
Females Males
E-1 (♂) 0 ♂, 28 ♀ G1 ♀ x WT* ♂ 57 29 26
E-2 (♂) 0 ♂, 42 ♀ G1 ♀ x WT ♂ 128 59 62
E-3 (♀) 6 ♂, 2 ♀ G1 ♂ x WT ♀ 81 76 0
E-4 (♀) 25 ♂, 26 ♀ G1 ♂ x WT ♀ 32 27 0
*WT, wild-type.
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The An. stephensi transgenic line attP43 has two φC31
attP docking sites in its genome [20]. Five hundred line
attP43 embryos injected with the attB-3×P3-DsRed2-
tetO-Nipp1Dm effector construct (OX3547) produced
178 (36% survival) adult mosquitoes (Table 3). The sur-
viving adults were reared as 11 male and eight female
pools and out-crossed with wild-type mosquitoes. The
progeny of four pools, designated E-1 to E-4, contained
transgenic individuals detected by fluorescence micros-
copy. The sex ratio of the progeny is consistent with
the inserted transgene being integrated into the XTable 4 Sex-ratio, survival, and flightless phenotypes in the F
driver lines engineered with either OX3545 (DAa-) or AsOX35
♂ driver lines outcrossed







DAa-1 775 144 0
DAa-2 1150 307 7
DAa-3 4340 880 9
DAa-4 600 110 3
DAa-5 900 226 47
DAa-6 1830 371 140
DAa-7 1200 239 41
DAs-17 nd 465 80
DAs-18 nd 89 11
DAs-19 nd 185 58
DAs-20 nd 152 11
DAs-21* nd 1545 0
DAs-22 nd 1483 3
DAs-24 nd 93 23
DAs-25* nd 761 0
DAs-26 nd 328 15
DAs-28 nd 244 19
DAs-29 nd 107 33
DAs-30 nd 226 15
DAs-34 nd 114 8
DAs-36 nd 267 21
*Lines with design-feature phenotypes.
**Crossing Das-22 and E-1 lines generated one flightless male (indicated in parenthchromosome. Genomic DNA extracted from G1 trans-
genic mosquitoes analyzed with Southern blots revealed
that the effector transgene was inserted into the same X-
linked φC31 attP docking site in all four integration
events (Figure 2). Adults of the four transgenic lines
were combined in a single population and named E-1.
Crossings of DAa driver and E-1 effector lines
Seven DAa driver lines (DAa1-7) were crossed with the ef-
fector line E-1 and the flight capabilities and sex ratio of
their progeny analysed (Table 4). Larvae hemizygous for
both driver and effector transgenes were identified by the1 progeny of crosses between the effector line E-1 and
45 (DAs-)
ic adults
males Flightless females Flying males Totals
(% survival larvae-adult)
1 62 63 (44%)
0 34 41 (13%)
172 345 517 (70%)
23 29 54 (49%)
0 96 143 (63%)
0 143 283 (76%)
6 74 121 (51%)
79 177 336 (72%)
3 23 37 (41%)
20 62 140 (75%)
0 52 63 (41%)
161 483 644 (42%)
397 507 (1)** 907 (61%)
4 28 55 (59%)
70 193 263 (35%)
86 112 213 (65%)
0 73 92 (37%)
0 33 66 (61%)
0 14 29 (12%)
0 0 8 (0%)
0 46 67 (25%)
esis).
Table 5 Effects of tetracycline on survival and flightless phenotype of transgenic Anopheles stephensi carrying driver
and effector transgenes
♂ driver lines outcrossed
















DAa-3 10 μg/ml 2535 371 108 16 226 350 (94%)
DAa-3 5 μg/ml 930 269 37 3 91 131 (49%)
DAa-3 1 μg/ml 610 143 21 10 69 100 (70%)
DAa-3 100 ng/ml 750 162 15 16 61 92 (57%)
DAa-3 10 ng/ml 600 127 9 28 38 75 (59%)
DAs-21 10 μg/ml nd 233 25 18 82 125 (54%)
DAs-22 10 μg/ml nd 628 155 12 285 (1)* 453 (72%)
*One flightless male was observed among the progeny of driver DAs-22 ♂ x effector E-1 ♀ cross (indicated in parenthesis).
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consistent with those produced by the 3×P3 and the IE1
promoters (Additional file 3: Figure S2).
Larvae carrying both the effector and the driver
transgenes are expected to represent 25% of the progeny.
Χ2 analyses of crosses between males from DAa lines and
E-1 females resulted in significantly reduced proportions
of double-hemizygous larvae relative to this expectation
(Χ2 from 11.79 to 184.11; df = 1, and p < 0.001 for all
crosses). These results support the interpretation that
some load is associated with carrying the transgenes. The
surviving double-hemizygous individuals were maintained
in the absence of tetracycline and allowed to develop into
adults. Crosses with driver line DAa-1 produced 97% adult
male progeny, reflecting significant lethality in developing
females. The single adult female recovered from this cross
exhibited a flightless phenotype. In contrast, crosses with
driver line DAa-6 males resulted in equal numbers of
adults of both sexes and no flightless phenotypes were ob-
served among the surviving females. In addition, the
flightless phenotype was not observed in any female of
crosses involving males from DAa-5 or DAa-2. Driver
lines DAa-3 and DAa-4 crossed with E-1 produced results
consistent with the design intent of the transgenes with
95% of the females exhibiting the flightless phenotype and
all males capable of flight.
Crossings of DAs driver and E-1 effector lines
Eight of 14 DAs driver lines produced progeny with a
flightless-female phenotype following crossing with the
effector line E-1 (Table 4). The majority of the female pro-
geny of lines DAs-24 (15% flightless) and DAs-18 (21%
flightless) was able to fly. Line DAs-17 produced similar
numbers of flying and flightless females. Lines DAs-26
and DAs-22 produced mostly flightless females (85% and
99% flightless, respectively) while DAs-21 and DAs-25
crosses with E-1 resulted in 100% flightless females. The
sex-ratios of the adult progeny resulting from DAs-21,
DAs-25 and DAs-22 crosses with E-1 are abnormal (Χ2from 13 to 160; df = 1, and p < 0.001 for all crosses) with
more males than females indicating some degree of female
lethality at the sub adult stages. No sex-associated lethality
was observed when crossing lines DAs-24, DAs-26, DAs-
17 and DAs-19 (Χ2 from 0.0 to 0.9; df = 1, and p > 0.2
for all crosses).
Tetracycline suppression of the flightless phenotype
Tetracycline provided to double-hemizygous transgenic
An. stephensi is expected to rescue the flightless-female
phenotype by preventing tTA binding to tetO and there-
fore inhibiting expression of the effector molecule
Nipp1Dm. Eggs (estivated embryos) were collected from
E-1 females mated with DAa-3, DAs-21 or DAs-22 driver
line males and allowed to develop either in the presence
or absence of tetracycline (Tables 4 and 5). The presence
of tetracycline results in adults of both sexes with the fly-
ing, wild-type phenotype. All adult males except one could
fly independent of the presence of tetracycline. In contrast,
98% (731/743 combined for DAa-3, DAs-21 and DAs-22;
Table 4) of the adult females reared in the absence of
tetracycline were flightless. The majority, ≥ 67%, of the fe-
males treated with ≥ 1 μg/ml tetracycline were able to fly,
while tetracycline concentrations of 100 and 10 ng/ml
only rescued partially (48 and 24%, respectively) the flight-
less phenotype (Table 5).
Conclusions
The results shown here demonstrate that the genetics and
resulting phenotypes of a female-specific RIDL strategy,
previously developed for dengue vector mosquitoes [2,4]
can be adapted to a vector of human malaria, An.
stephensi. This demonstration supports efforts to optimize
the efficacy of the gene constructs and to eventually per-
form cage and field trials to assess the usefulness of this
approach as a malaria vector population suppression tool.
It is clear that further refinements of this system are
required. Efficient scale-up would benefit from having to
manage only a single line, so linkage of the driver and
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more, piggyBac-mediated transposition was used to in-
sert randomly the driver constructs into the mosquito
genome. The expectation was that position effects
resulting from the activity state of the DNA surrounding
each independent insertion site would influence in a
variable manner the expression of the driver construct.
This was evident in variable penetrance of the intended
flightless phenotype and the sex-independent and
-dependent lethality in some lines. Remarkably, South-
ern blot analyses showed that all of the recovered driver
lines carrying the AeAct-4 promoter and at least two of
those carrying the AsAct-4 promoter had single trans-
gene insertions. This is unusual for piggyBac integration
into An. stephensi [20,24] and supports the conclusion that
the driver construct alone can be deleterious if present in
high-copy number as well as being integrated at a chromo-
somal site that enhances its expression. Selection and
characterization of favourable chromosomal docking sites,
site-specific recombination and DNA fragments with
insulator-like activity would assist the development of a
strain with the optimized flightless phenotype and diminish
or eliminate male fitness impact [20,24,25].
Scale-up in testing of novel genetic strains is needed
to ensure that the engineered mosquitoes function as
designed in the field. The Ae. aegypti fsRIDL line
OX3604C had outstanding performance characteristics
in small and large laboratory cage trials, but did not
meet efficiency expectations derived from modelling
when tested in large outdoor field cages [7,8]. It is im-
portant to note that the field-cage trials were limited to
only one test of a single, independently-derived fsRIDL
strain. Here again, strain optimization using alternative
characterized genome insertion sites, DNA insulator se-
quences [24] and even redesigning the transgenes could
produce a strain that can be used with the expectation
of an epidemiological impact on pathogen transmission.
The translation of new technologies from the labora-
tory to the field requires that resulting products function
in a safe and efficacious manner. Transgenic mosquito
technologies bring with them a number of challenges
that can be addressed in the design features of the final
products and site-specific community engagement activ-
ities [26-28]. A specific concern about the conditional,
dominant, lethal genes is whether environmental con-
tamination by tetracycline could produce a hazard by
rescuing the flightless phenotype in the released trans-
genic mosquitoes. The most plausible source of rescue
would be tetracycline contaminating larval habitats. No
reports exist of measurements of tetracycline in the
urban breeding sites of An. stephensi. However, there is
an extensive literature on the widespread use of antibi-
otics for therapeutic, prophylactic and growth promotion
purposes in livestock production. Antibiotics, includingtetracycline and its analogues, are transferred to soils
and surface waters when manure from the animals is
spread on farmland or held in wastewater ponds. Several
studies have been conducted to measure the concentra-
tions of antibiotics in wastewater, animal waste and
soil from manure-treated farmland. In studied sites, con-
centrations of tetracycline, tetracycline analogues or
tetracycline degradation products were found to be
lower than 1 μg/ml. One of the highest numbers mea-
sured was 0.698 ng/ml tetracycline in farmland treated
with pig-manure slurry [29]. Other locations, such as
waste-water treatment facilities, where persistent tetracyc-
line could come from various sources such as cities and
rural areas, had a maximum tetracycline concentration of
0.004 μg/ml [30]. The highest detected concentration of
chlortetracycline in the same study was estimated at
0.0012 μg/ml. These concentrations are atypical, though.
Bodies of water such as rivers and streams where runoff
from farms could potentially be problematic contained
minimal amounts of tetracycline, with concentrations
below the limit of detection (≤ 0.5 ng/ml) [31]. Reviews
examining tetracycline levels measured in waste-water
treatment plants in USA and Asia found concentrations in
the range <0.00003-0.62 ng/ml [32,33]. These data indi-
cate that environmental tetracycline (and tetracycline
analogue) concentrations detected in the breeding sites in
which An. stephensi larvae are most likely to be located
are not sufficient to rescue the engineered mosquito flight-
less phenotype.
Anopheles stephensi is an important malaria vector in
the Indian subcontinent. Therefore the management of
An. stephensi populations is of prime importance to public
health and welfare. Successful population suppression
could result in local or regional vector elimination
dependent on the scope and size of the effort. It is antici-
pated that this suppression would result in less parasite
transmission and therefore reduced human morbidity and
mortality. However, population suppression technologies
would have to be sustained to prevent re-colonization of
the treated areas following vector migration or natural- or
human-aided dispersal. Sustainable transgenic technolo-
gies also are being developed and these may represent
second-generation genetic tools for controlling parasite
transmission [25]. In the interim, the data presented here
support the conclusion that fsRIDL should be developed
as a tool in integrated pest management practices to
control malaria transmission in urban settings were
An. stephensi is the major vector.
Additional files
Additional file 1: Figure S1. Primary nucleic acid sequence and
schematic representation of the Anopheles stephensi Actin-4 gene.
A) Capitalized nucleotide sequences correspond to exons 1 and 2,
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http://www.malariajournal.com/content/12/1/14296 and 1155 nt in length, respectively, while lower case indicates the
1012 nt 5′-end flanking sequence and the 271 nt intron. Underlined
sequences indicate the locations of primers described in the manuscript
and the transcription (+1) and translation (ATG) start sites are indicated
underlined and in bold. B) Exons 1 and 2 (red boxes), the 5′ flanking
sequence (green box) and the intron (yellow box) of the An. stephensi
Actin-4 gene. Lines underneath indicate the positions of the 1400 nt long
AsActin4 regulatory region used to generate AsOX3545, the 5′ RACE
product that identified the transcription start-site and the RT-PCR product
utilized to determine the gene expression profile. C) Gene amplification
analysis of the expression profile of AsAct-4. The 536 nt amplicon is
specific for the gene product. Template mRNA samples were derived
from larvae (L), pupae (P) and adults (A). An amplification product
specific to the 18s rRNA is the positive sample control.
Additional file 2: Table S1. Sex ratio and survival of Anopheles
stephensi driver transgenic lines (DAa-) carrying the construct OX3545.
Additional file 3: Figure S2. Anopheles stephensi larvae hemizygous for
driver and/or effector transgenes were identified by patterns of DsRed2
fluorescence consistent with those produced by the 3XP3 and the IE1
promoters. DAa-3 larvae display a scattered fluorescence pattern
throughout the body driven by the IE1 promoter (A) while DsRed2
expression in the effector line E-1 is driven by the eye-specific promoter,
3XP3 (B). Larvae hemizygous for both driver and effector transgenes
(C) were identified by patterns of DsRed2 fluorescence in their eyes and
bodies. Wild-type (WT) shows the fluorescence background of wild type
non-transgenic An. stephensi larvae.
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